Cardiac allograft vasculopathy: prevention and treatment options.
Weis
Michael
M
Stanford University School of Medicine, Division of Cardiovascular Medicine, Stanford, California, USA. michaelweis@yahoo.com
D003327:Coronary Disease / Q000517:prevention & control*; D004110:Diltiazem / Q000627:therapeutic use*; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods; D011183:Postoperative Complications / Q000473:pathology / Q000517:prevention & control*; D014184:Transplantation, Homologous / Q000473:pathology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D004110:Diltiazem